MSTN and chronic kidney disease: Given that endothelial cells from CKD patients are exposed to elevated levels of both myostatin and indoxyl sulfate, we hypothesized that these two components of the uremic milieu may synergistically contribute to endothelial dysfunction by impairing endothelial proliferation and promoting a pro-inflammatory phenotype.